Data / Research funding / International Agency for Res on Cancer
International Agency for Res on Cancer: 12 NIH awards ($18.8M), fiscal years 2021 to 2026
International Agency for Res on Cancer in Lyon is funded under 12 NIH awards ($18.8M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- HSMZYXZ7M358UEI
Awards
12 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| IARC Monographs on the Identification of Carcinogenic Hazards to Humans | NIH | National Cancer Institute | 2021 to 2025 | $4,871,949 | September 1, 1985 | March 31, 2027 | SCHUBAUER-BERIGAN, MARY K. | reporter.nih.gov |
| InterLymph Consortium: interrogating pleiotropy and gene by environment interactions among hematopoietic malignancies. | NIH | National Cancer Institute | 2021 to 2025 | $2,685,053 | September 3, 2021 | August 31, 2026 | MCKAY, JAMES DOWLING | reporter.nih.gov |
| The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening | NIH | National Cancer Institute | 2022 to 2025 | $1,995,233 | September 8, 2022 | August 31, 2027 | ROBBINS, HILARY A. | reporter.nih.gov |
| A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs | NIH | National Cancer Institute | 2023 to 2025 | $1,730,892 | August 15, 2023 | July 31, 2028 | BASU, PARTHA | reporter.nih.gov |
| African Breast Cancer - Disparities in Outcomes - Plus (ABC-DO Plus) | NIH | National Cancer Institute | 2021 to 2023 | $1,451,458 | August 1, 2020 | April 30, 2025 | MCCORMACK, VALERIE | reporter.nih.gov |
| PROMINENT - IARC | NIH | National Cancer Institute | 2022 to 2024 | $1,345,330 | June 22, 2022 | May 31, 2025 | BRENNAN, PAUL JOSEPH | reporter.nih.gov |
| Development, field testing and evaluation of the efficacy of a hand-held, portable and affordable thermo-coagulator to prevent cervical cancer in low- and middle-income countries | NIH | National Cancer Institute | 2021 to 2023 | $1,235,802 | July 7, 2016 | February 29, 2024 | BASU, PARTHA | reporter.nih.gov |
| The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer risk | NIH | National Cancer Institute | 2024 to 2025 | $1,157,721 | April 1, 2024 | March 31, 2029 | SHEIKH, MAHDI | reporter.nih.gov |
| Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | NIH | National Cancer Institute | 2021 | $1,106,503 | June 1, 2016 | May 31, 2023 | ALMONTE, MARIBEL | reporter.nih.gov |
| The role of germline and somatic DNA mutations in oral and oropharyngeal cancers | NIH | National Institute of Dental & Craniofacial Research | 2021 | $706,129 | January 10, 2017 | December 31, 2022 | BRENNAN, PAUL JOSEPH | reporter.nih.gov |
| The role of Epstein Barr Virus and Human Papilloma Virus Co-infection in Conjunctival Squamous Cell Carcinoma. | NIH | National Cancer Institute | 2021 to 2022 | $288,712 | July 1, 2021 | June 30, 2024 | GHEIT, TARIK | reporter.nih.gov |
| Germline risk of oral and oropharyngeal cancers across diverse populations | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $221,817 | August 1, 2021 | July 31, 2024 | VIRANI, SHAMA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 5 | $3,486,153 | 0 | $0 |
| 2024 | 6 | $3,485,042 | 0 | $0 |
| 2023 | 7 | $3,721,581 | 0 | $0 |
| 2022 | 8 | $3,319,639 | 0 | $0 |
| 2021 | 8 | $4,784,184 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Cancer
- Prevention
- Clinical Research
- Infectious Diseases
- Cancer Genomics
- Genetics
- Human Genome
- Rare Diseases
- Sexually Transmitted Infections
- Cervical Cancer
- Digestive Diseases
- Health Services
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.